Who owns the GLIAPHARM trademark?

The GLIAPHARM trademark is owned by Gliapharm SA.

What is the serial number for GLIAPHARM?

The USPTO serial number for GLIAPHARM is 79205568.

What is the registration number for GLIAPHARM?

GLIAPHARM is registered under USPTO registration number 5298874.

GLI

USPTO Trademark Record

REGISTERED

GLIAPHARM

Q: What class is the GLIAPHARM trademark registered in?

The GLIAPHARM trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79205568·Reg 5298874·Filed Dec 29, 2016

Owner Gliapharm SA

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GLIAPHARM (Serial No. 79205568), Registration No. 5298874, is a registered US trademark filed on Dec 29, 2016 by Gliapharm SA. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

renewal 10y period: October 04, 2027356 days remaining

Mark Intelligence

GLIAPHARM (Reg. #5298874) is a registered US trademark that has been protecting its owner, Gliapharm SA, since 2016. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 29, 2016

SERIAL

79205568

REG#

5298874

REGISTERED

Oct 03, 2017

Owner

Applicant

Gliapharm SA

Entity

S.A. (French / Swiss)

Address

Chemin de Richesson 31, Lausanne 26, CH-1000

Country

Attorney

NameFlavia Campbell

Law firm

Flavia Campbell DICKINSON WRIGHT PLLC

Address

1850 North Central Avenue, Suite 1400, Phoenix, AZ 85004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 29, 2016

Serial Number79205568

Registration No.5298874

Registration DateOct 03, 2017

Status DateDec 12, 2024

Published for OppositionJul 18, 2017

Mark TypeDesign with words

Status DescriptionLive and registered, partial Section 71 and 15 accepted

Filing Signals

FILED

2016

YEARS AGO

10y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

36 events

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Oct 03, 2026

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

NEW REPRESENTATIVE AT IB RECEIVED

Jul 02, 2026

NEW REPRESENTATIVE AT IB RECEIVED

PARTIAL INVALIDATION PROCESSED BY THE IB

Feb 19, 2026

PARTIAL INVALIDATION PROCESSED BY THE IB

INVALIDATION PROCESSED

Feb 03, 2026

INVALIDATION PROCESSED

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Feb 03, 2026

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Aug 12, 2025

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

Dec 12, 2024

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Dec 12, 2024

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 18, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 71 & 15 RECEIVED

Apr 02, 2024

TEAS SECTION 71 & 15 RECEIVED

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Oct 03, 2022

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 16, 2018

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jan 18, 2018

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jan 18, 2018

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 03, 2018

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Oct 03, 2017

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jul 18, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 18, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 28, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jun 06, 2017

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jun 06, 2017

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 06, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jun 06, 2017

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 06, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 03, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 02, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 02, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

May 27, 2017

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 11, 2017

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 11, 2017

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 06, 2017

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

May 05, 2017

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

May 02, 2017

APPLICATION FILING RECEIPT MAILED

ASSIGNED TO EXAMINER

Apr 28, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 27, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 20, 2017

SN ASSIGNED FOR SECT 66A APPL FROM IB

GLIAPHARM

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Flavia Campbell

Resources

Company